Frequency of plasmid-mediated AmpC in enterobacteriaceae isolated in a Brazilian teaching hospital

Brazilian Journal of Microbiology

Volumn 44, Issue 2, 2013, Pages 477-480

  Campana, Eloiza H ^a   Barbosa, Paula P ^a   Fehlberg, Lorena C C ^a   Gales, Ana C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Beta lactamases; Beta lactams; Brazil; Plasmids

Indexed keywords

AMPC BETA-LACTAMASES; BACTERIAL PROTEIN; BETA LACTAMASE;

ANALYSIS; BRAZIL; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; PLASMID; TEACHING HOSPITAL;

BACTERIAL PROTEINS; BETA-LACTAMASES; BRAZIL; HOSPITALS, TEACHING; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PLASMIDS;

EID: 84885742856     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822013000200023     Document Type: Article

References (15)

1. Bauernfeind A, Stemplinger I, Jungwirth R, Giamarellou H (1996) Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother 40:221-224.
2. Carvalhaes CG, Picão RC, Nicoletti AG, Xavier DE, Gales AC (2010) Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: Be aware of false positive results. J Antimicrob Chemother 65:249-251.
3. Castanheira M, Pereira AS, Nicoletti AG, Pignatari AC, Barth AL, Gales AC (2007) First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America. Antimicrob Agents Chemother 51:1527-1529.
4. Clinical and Laboratory Standards Institute (2009) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically. Eighth Edition. CLSI document M7-A8. Clinical and Laboratory Standards Institute Wayne.
5. Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne.
6. Coudron PE, Moland ES, Thomson KS (2000) Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a Veterans Medical Center. J Clin Microbiol 38:1791-1796.
7. Dias RCS, Borges-Neto AA, D'Almeida Ferraiuoli GI, de-Oli-veira MP, Riley LW, Moreira BM (2008) Prevalence of AmpC and other P-lactamases in enterobacteria at a large urban university hospital in Brazil. Diagn Microbiol Infect Dis 60:79-87.
8. Jacoby GA (2009) AmpC beta-lactamases. Clin Microbiol Rev 22:161-182.
9. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broadspectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867-878.
10. Lee K, Hong SG, Park YJ, Lee HS, Song W, Jeong J, Yong D, Chong Y (2005) Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactama-ses-producing isolates of Escherichia coli and Klebsiella pneumoniae. Diagn Microbiol Infect Dis 53:319-323.
11. Pavez M, Neves P, Dropa M, Matté MH, Grinbaum RS, Elmor de Araújo MR, Mamizuka EM, Lincopan N (2008) Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC beta-lactamase in Brazil. J Med Microbiol 57:1590-1592.
12. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lacta-mases: A clinical update. Clin Microbiol Rev 18:657-686.
13. Pérez-Pérez FJ, Hanson ND (2002) Detection of plasmid-me-diated AmpC beta-lactamase gene in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153-2162.
14. Philippon A, Arlet G, Jacoby GA (2002) Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Che mother 46:1-11.
15. Thomson KS (2001) Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis 7:333-336.